TipRanks
Go Ultimate55% OFF

Bioxcel Therapeutics (BX20) Cash flow

Bioxcel Therapeutics Cash Flow

DE:BX20's free cash flow for Q2 2026 was $-6.10M. For the 2026 fiscal year, DE:BX20's free cash flow was increased by $0.00 and operating cash flow was $-6.10M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
$ -57.62M$ -72.03M$ -155.01M$ -135.34M$ -82.15M
$ 0.00$ 0.00$ -20.00K$ -139.00K$ -445.00K
$ 56.52M$ 36.66M$ 26.52M$ 96.24M$ 102.45M
$ 28.76M$ 29.85M$ 65.22M$ 193.72M$ 232.97M
$ -57.62M$ -72.03M$ -155.03M$ -135.48M$ -82.60M

Currency in USD

Bioxcel Therapeutics Cash Flow

-200M-100M0100M200M300M201720182019202020212022202320242025OperatingInvestingFinancing